NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

ABSI | NASDAQ

$10.75 -$0.02 | -0.19%
SIGNAL:Signal available — unlock to view |2026-09-25 |F&G 63 |RSI 62.8

Company Overview:

Market Cap: $1.84B
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $2.24 - $12.06

5.2 Year ABSI Performance Metrics:

Total Return (with DRIP): -50.2% (-12.55% CAGR)
Total Return (no DRIP): -50.2% (-12.55% CAGR)
Share Price: -50.2% (-12.55% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $4,979
Total Return $ (with DRIP): -$5,021
ABSI Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
ABSI Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

ABSI Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ABSI - Revenue
ABSI Revenue CAGR:1Y: -46.37%2Y: -49.96%5Y: -15.27%10Y: 0.00%
ABSI - Earnings Per Share (EPS)
ABSI EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Net Income
🔓 See the full chart40% off right now · 7-day free trial
ABSI Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
ABSI EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
ABSI Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
ABSI Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
ABSI Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
ABSI Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
ABSI Shares Outstanding CAGR:1Y: 23.42%2Y: 18.08%5Y: 11.75%10Y: 0.00%
ABSI - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
ABSI Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
ABSI Stock-Based Comp CAGR:1Y: 10.27%2Y: -0.45%5Y: 29.46%10Y: 0.00%
ABSI - Expenses
🔓 See the full chart40% off right now · 7-day free trial
ABSI Expenses CAGR:1Y: -99.55%2Y: -94.52%5Y: -85.87%10Y: 0.00%
ABSI - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
ABSI - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
ABSI - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
ABSI - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
ABSI - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
ABSI - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
ABSI - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
ABSI Revenue CAGR:1Y: -46.37%2Y: -49.96%5Y: -15.27%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ABSI - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABSI Actual Revenue CAGR:1Y: -46.37%2Y: -49.96%5Y: -15.27%10Y: 0.00%
ABSI - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABSI Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABSI Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
ABSI Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ABSI - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
ABSI Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
ABSI Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
ABSI Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
ABSI Price To Sales Ratio CAGR:1Y: 937.90%2Y: 363.06%5Y: 16.45%10Y: 0.00%
ABSI - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
ABSI Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ABSI - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
ABSI Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for ABSI

Based on past 5.2-year performance, here are ABSI growth metrics:

Share price CAGR of -12.55%
Dividend CAGR of +0%

Using ABSI CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ABSI (DRIP)ABSI - No DRIP
Current Price$10.75$10.75
Start Shares930.23930.23
Start Value$10,000$10,000
  
After 10 years:
Final Share Count930.23930.23
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$2.81$10.75
Total Dividends$0$0
Final Value$2,616$10,000

Estimated Future Value + Dividends - ABSI

NOTE: Above numbers are our estimate based on ABSI's Dividend and Price CAGR over past 5.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Absci Corporation (ABSI) had its IPO on 2021-07-22, and is traded on NASDAQ stock exchange.

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

ABSI website: https://www.absci.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — ABSI

Value from:
Pay up to today
—
vs current price $10.75
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →